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Abstract
Background: Nicotine use has been reported to ameliorate symptoms of Attention-Deficit/Hyperactivity Disorder
(ADHD). Furthermore, adults with ADHD have a relatively high prevalence of cigarette smoking and greater difficulty
abstaining from smoking. Overall, though, there is scant literature investigating the beliefs, perceptions and
experiences of smokers with ADHD regarding smoking cessation and withdrawal.
Methods: Our participants (n = 20) fulfilling criteria for ADHD and a past or current dependence from nicotine were
recruited from the in- and outpatient clinic of the Zurich University Psychiatric Hospital and the Psychiatric Services
Aargau (Switzerland). We conducted in-depth interviews to explore their motivations to quit, past experiences with
and expectations about quitting using a purposeful sampling plan. The sample was selected to provide diversity in
relation to level of nicotine dependence, participation in a smoking-cessation program, gender, age, martial status
and social class. Mayring’s qualitative content analysis approach was used to evaluate findings.
Results: Adult smokers with ADHD had made several attempts to quit, experienced intense withdrawal symptoms,
and relapsed early and often. They also often perceived a worsening of ADHD symptoms with nicotine abstinence.
We identified three motives to quit smoking: 1) health concerns, 2) the feeling of being addicted, and 3) social
factors. Most participants favored a smoking cessation program specifically designed for individuals with ADHD
because they thought ADHD complicated their nicotine withdrawal and that an ADHD-specific smoking cessation
program should address specific symptoms of this disorder.
Conclusions: Since treatment initiation and adherence associate closely with perception, we hope these findings
will result in better cessation interventions for the vulnerable subgroup of smokers with ADHD.
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Background
Adults diagnosed with Attention- Deficit/Hyperactivity
Disorder (ADHD) exhibit significantly higher rates of
harmful use of or dependence on nicotine than persons
without this neuropsychiatric disorder, with comorbidity
rates as high as 35 to 55 % in United States samples [1, 2].
Similar comorbidity rates are found in Europe [3].
Patients with ADHD suffer from symptoms of inatten-
tion and hyperactivity-impulsivity that result in a diverse
range of psychosocial impairments [4]. Small, prospective
clinical trials have suggested that nicotine may reduce
symptoms of ADHD [5, 6], supporting a “self-medication
hypothesis;” i.e., some individuals with ADHD may begin
smoking as an attempt to manage deficits in attention and
concentration [7, 8]. The self-medication hypothesis is fur-
ther supported by research on patients with ADHD show-
ing beneficial effects of nicotine on concentration [9],
sustained attention [10], and regulation of emotional dys-
function [11]. Although the self-medication hypothesis is
not undisputed [12], it may help explain why patients with
ADHD begin smoking at an earlier age, smoke more
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frequently, and are less likely to maintain abstinence com-
pared to smokers without ADHD [13–15].
More recent research on ADHD and smoking has in-
vestigated the link between specific ADHD subtypes
(e.g., combined type, predominantly inattentive type, and
predominantly hyperactive-impulsive type) and certain
clinical characteristics, including levels of nicotine use,
withdrawal symptoms, abstinence rates, treatment readi-
ness, and treatment response [2, 13, 15, 16]. Results
from these few studies are mixed, but one study of 276
adolescents with ADHD and a comorbid (non-nicotine)
substance use disorder (SUD) did not find differences in
treatment response among ADHD subtypes, implying
that subtype designation may have limited relevance for
treatment planning [16].
In a previous study published in the same journal we
explored how patients with adult ADHD, who currently
smoked, viewed the relationship (or link) between nico-
tine use and ADHD [17]. We identified two explanatory
models linking ADHD and tobacco use: smoking as
attempt of self-medication and smoking as a social be-
havior. Participants viewed the use of nicotine rather
positively—considering it a therapeutic aid—and they
reported positive effects on psychopathological symp-
toms (relieving “inner tension”), cognitive, and social
functioning. In the present study, we expand this work
by focusing specifically on beliefs, perceptions and ex-
periences of smokers with ADHD regarding smoking
cessation and withdrawal.
In the general population, non-ADHD smokers attribute
cigarette smoking to beneficial psychological, physiological
and social effects [18, 19]; experience quitting as difficult
[20]; and frequently relapse [21, 22]. With this in mind,
we aimed to assess the motivations, expectations, and
experiences of patients with ADHD with regard to smok-
ing cessation and withdrawal, since previous studies have
demonstrated that these subjective factors at least par-
tially predict future quitting attempts [23] and relapse
[24]. We also explored patients’ reasons for participa-
ting in a cessation program and on their thoughts about
an “optimal” smoking cessation intervention.
Especially in light of the lack of evidence-based guide-
lines for the treatment of comorbid ADHD and SUD
[25], these questions are of clinical importance. It is in-
creasingly understood that treatment plans that do not
take into account subjective perceptions are unlikely to
increase help-seeking behavior and are therefore asso-
ciated with negative treatment outcomes [26].
Methods
Participants and procedure
Data were collected during a series of qualitative inter-
views with adult smokers with ADHD in treatment either
at the ADHD consultation service at the Centre for
Addiction Disorders, an outpatient facility of the Zurich
University Hospital (12) or the Psychiatric Services
Canton Aargau (8).
A mixed method of purposeful sampling and saturation
sampling principles was used. The sample was selected to
provide diversity in relation to (1) level of nicotine de-
pendence (very low to very high); (2) clinical experience
(previous in- and outpatient treatment episodes), inclu-
ding comorbidity (affective disorders, neurotic disorders,
personality disorders, gender (male/female), age (25–54),
martial status (married, single, divorced), social class
(professional, skilled, unskilled, unemployed, recipient
of welfare or disability compensation) and immigration
status (citizens, permanent residents). We also sampled
for participants who had participated in the smoking
cessation program (8) and for those who had not (12).
Zurich participants were recruited from a larger
sample of 134 participants who had participated in an
epidemiological study of the association between ADHD
and tobacco use [3, 27]. Depending on the questionnaire
used, participants reached average test scores of 40.0
(SD = 11.13) on WURS-k, 29.2 (SD = 8.99) on ADHS-SB
and 15.4 (SD = 7.7) on the newly developed SCL-ADHD
scale [28]. In this sample, fifty-five participants of the
larger epidemiological study qualified for inclusion: they
were diagnosed with ADHD, currently using tobacco,
and at least 18 years of age. We were able to reach 48 of
them and 12 agreed to participate.
Prior being interviewed, eight out of these 12 subjects
recruited had participated in a smoking cessation
program that was modeled after recommendations by
Cornuz et al. [29] and the U.S. Public Health Service,
Office of the Surgeon General [30]. It consisted of five
standardized counseling interviews based on cognitive
behavioral therapy techniques. Additional pharmaco-
logical support, including bupropion and nicotine replace-
ment therapy, was offered to participants. The counseling
sessions took place within the first three months, and two
additional follow-up visits were scheduled at six and
12 months. Additional appointments were made at the
request of the participants. Initial counseling focused
on smoking history, psychoeducation about nicotine
dependence, trigger situations, motivations for smoking,
pharmacotherapy, and developing a plan to quit. There-
after, participants were counseled on emotional reactions
to success or failure, withdrawal symptoms, weight gain,
and behavioral strategies to prevent relapse. During all
sessions participants received strong encouragement from
the therapist.
Additionally, we interviewed eight subjects from the
Psychiatric Services Aargau who had not participated in
a cessation program to obtain a greater variation of
themes and motives.
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Subjects who declined specifically named barriers to
participation in a few instances. Lack of time was the
most common reason why potential participants de-
clined inclusion in this study. Additionally, three poten-
tial participants agreed to be interviewed, but missed
their appointment. Attempts to contact these subjects
again were not successful.
Interviews explored the following topics: 1) past experi-
ences with smoking cessation and withdrawal, including
strategies used; 2) motivations, expectations, and reasons
for participating in a cessation program; 3) thoughts about
an “optimal” smoking cessation intervention; and 4) per-
ceptions about a smoking cessation program specifically
designed for adults with ADHD.
Assessment of ADHD and nicotine dependence
Prior to inclusion, all participants had a complete
evaluation of their ADHD in accordance with current
diagnostic recommendations [31] using the Wender-
Reimherr Interview (WRI) a German version of the
American Wender-Reimherr Adult Attention Deficits
Disorders Scale (WRAADDS), the Wender Utah Rating
Scale (WURS-k) [32], and the Attention-Deficit/Hyper-
activity Self-Report Scale (ADHS-SB) [33].
Additionally, researchers had access to a complete
clinical chart on each subject, including biographical
data and comorbid psychiatric diagnosis according to
the 10th revision of the International Statistical Classifica-
tion of Diseases and Related Health Problems (ICD-10).
Nicotine dependence was assessed using the six-item
Fagerstrom Test for Nicotine Dependence (FTND) [34],
and abstinence (for those participating in the smoking ces-
sation program) was evaluated by self-report and expired-
air carbon monoxide level [35].
Data collection and analyses
The qualitative interviews each lasted between 20 to
60 min and were digitally recorded and transcribed ver-
batim. Interviews were conducted by two researchers
(AF/RN), and participants chose the interview locations
so they felt free to fully express their own views and
perceptions [36]. Interviews began with narrative open-
ing questions, and a topic guide was used as part of a
flexible interview framework in order to capture beliefs
that were not spontaneously addressed by participants’
initial narratives.
Mayring’s qualitative content analysis approach was
used to evaluate findings. This framework constitutes an
controlled approach for empirical and methodological
qualitative analysis of texts within their context of com-
munication, following content analytical rules and step-
by-step models, without rash quantification and not
aiming to test a specific hypothesis [37]. In other words,
the data were allowed to “speak for themselves”, as op-
posed to approaching the data with existing presump-
tions. Interview data were coded using an inductive
qualitative procedure. The resulting categories were dis-
cussed by the research team to validate ratings and
achieve consensus. AF and RN applied the final code, and
consistency was confirmed through blind dual coding of
transcripts with ML. Participant recruitment continued
until we reached saturation of the data, in that there were
no new themes emerging and we had tested all the cat-
egories for disconfirming variations. MAXqda software
[38] was used for text management and interpretation.
This study was authorized by the local ethics committee.
We reported this study using COREQ guidelines [39].
Results
A total of 20 participants demonstrating a range of nico-
tine dependence were interviewed. The mean age of the
participants was 38.95 years ± SD 9.55 (median 42.0 years,
range 25 to 54 years). At the time of interview, partici-
pants smoked an average of 24.35 ± SD 9.64 cigarettes per
day (median 26.50, range 1 to 35). All subjects were
receiving psychotropic medications, most commonly
stimulants, but also antidepressants and (in two cases)
antipsychotics. Eight (40 %) participants used other
substances, most commonly alcohol, while the other
twelve (60 %) abstained from any substance.
Participants’ characteristics, diagnosis, and tobacco
consumption patterns are described in Table 1.
Past experiences with smoking cessation and withdrawal
Most participants, regardless of whether they had parti-
cipated in the smoking cessation program, had attempted
to quit smoking several times in the past. Only three
subjects had never tried to stop smoking.
“…There were certainly eight attempts [of quitting
smoking]…”
Mrs. F.
“Around four – to five times…”
Mrs. G.
Cessation efforts had resulted in a diverse length of
abstinence ranging from days to years.
“I stopped once for 6 months, that is a long time ago
when I was 22. The last time I made it for four days.”
Mrs. J.
“…the only longer period…where I had the feeling of
being out of the woods…was for one month…”
Mr. K.
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“…The longest period was one year of not smoking…”
Mrs. G.
Some participants considered smoking cessation rela-
tively easy, with only minor complications:
“…nothing big…well, the first three days more
psychologically, that I was thinking about it.
But physically I did not notice anything…certainly
more nervous though”
Mrs. H.
“…I experienced no withdrawal symptoms, maybe a
little restlessness…”
Mrs. E.
The majority of participants, however, experienced
attempts to quit as highly stressful and described severe
difficulties during those attempts, regardless of whether
they had made a conscious decision to quit or they were
forced to quit by external circumstances.
“…and stopping is so tedious, it fills your mind all day
and all night, that you are always thinking about it…
you always think you must not smoke, it becomes the
primary objective. And then I get in to panic that will
go on until life’s end…it is exhausting…”
Mrs. J.
“I noticed then, that it needs, after such a long time,
I am now 53 years old, and I got used to a lot of this
stuff and then I noticed the motivation is there, but it
is really tough to pull it through…”
Mr. A.
Most often, subjects had experienced symptoms of
irritability, nervousness, and restlessness, sometimes
accompanied by difficulty sleeping or symptoms of de-
pression and anxiety.
“Nervousness, restlessness, the permanent back and
forth, not knowing what it is all about [starts
laughing]…I forgot to go get groceries, and I just
noticed it at night, and then I forgot it again, because
I was so busy, and then I had to get out again…back
then…I started sweating and it was difficult to
concentrate, but no sleeplessness…”
Mrs. F.
“…I started to cry because of little things, although
I am usually not someone who starts crying, that
was bad, tragic…and the irritability, I could not
bear anything, I had to cry the entire time and
was furious…”
Mrs. G.
“…one time I had sleep issues, the other times I did
not have that. And then the devil in your body.
That was the worst for me. Always: now a cigarette,
a cigarette, that would be good now, simply, such a
chase, now you have to have one…”
Mrs. G.
Table 1 Participants’ characteristics, diagnosis, and nicotine
consumption patterns
n %
Number of participants 20
Gender
female 10 (50.0)
male 10 (50.0)
ADHD subtype according to DSM-IV TR
combined 13 (65.0)
hyperactive/impulsive 6 (30.0)
inattentive 1 (5.0)
Nicotine dependence according to Fagerström
very low 2 (10.0)
low 1 (5.0)
moderate 1 (5.0)
high 8 (40.0)
very high 8 (40.0)
Medication at time of interview
stimulants 13 (65.0)
antidepressants 11 (55.0)
mood stabilizers 2 (10.0)
antipsychotics 2 (10.0)
Previous phases of nicotine abstinencea
none 5 (25.0)
<1 month 5 (25.0)
1 - 12 months 6 (30.0)
>1 year 4 (20.0)
Number of comorbid psychiatric diagnosis groups except for ADHD
and nicotine dependence
none 2 (10.0)
one 10 (50.0)
more than one 8 (40.0)
Comorbid psychiatric diagnosis groups except substance
use disorders (ICD-10)
schizophrenia 1 (2.4)
mood disorders 3 (15.0)
neurotic disorders 4 (20.0)
personality disorders 3 (15.0)
aas of the time of interview, self reported, where possible chart verified
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“…the first few days were nasty…it was a physical
malaise and…also psychologically. I am not easy
to talk to, on the edge and bad tempered…”
Mr. K.
Some participants who experienced these difficulties
described the use of other psychotropic substances to
cope:
“…I noticed that I got depressed and aggressive and
that something was missing…and than I started to
drink more, and that was a direct consequence. That
is why I knew it was alright to drink a bit more…”
Mr. A.
Others noticed a change in their caffeine use or eating:
“ …for a time I drank more coffee…”
Mrs. E.
“…I had a much increased appetite for candy and
sweets, what I usually don’t have…”
Mr. K.
Less frequently, other side effects were noted; for
example, a perceived increase in weight:
“… I was totally shocked when I stopped [without
counseling], what happened back then…when I gain
weight that is a huge problem. I can not accept that, I
don't want to be 4–5 kg more than I am now, and I
don't want to be a nervous wreck. I can not afford that
with my children. The last time I tried to quit I almost
had a nervous breakdown, and that was shocking.”
Mrs. G.
Notably, almost all participants who experienced dif-
ficulties associated these symptoms with immediate
nicotine withdrawal. Since symptoms of ADHD can be
difficult to differentiate from nicotine withdrawal symp-
toms, participants where further asked to elaborate on
this issue. The question of whether smoking cessation
had a lasting influence on symptoms of ADHD was
addressed by half of the participants. While one par-
ticipant denied that symptoms of ADHD had gotten
worse, all others were convinced that smoking cessa-
tion had resulted in a worsening of ADHD symptoms
even after immediate physical symptoms of withdrawal
had subdued.
“… I get even more erratic and aimless, I walk the
entire house and don’t remember what I had planned
to do, why and where, I just jump around…”
Mrs. J.
“… It amplified [symptoms]…my strategies to calm
myself down were not working anymore…”
Mr. I.
Independent of withdrawal symptoms, some partici-
pants viewed external social factors as the most prob-
lematic experience after ceasing the use of cigarettes.
“Actually I didn’t have big problems, during that time,
I mean the biggest problem I had was my partner,
because he smokes and we were together for such a
long time, and then I was smoking with him and that
was a problem…”
Mrs. C.
Only a minority of participants had tried to quit smok-
ing without treatment, conventional or otherwise. Subjects
had used medications (bupropion, nicotine replacement
therapy) as well as alternative methods like acupuncture
(two) and magentopathy (one) in various combinations.
While pharmaceutical support was experienced as some-
what helpful in attenuating symptoms of withdrawal, acu-
puncture was not considered helpful and “magnetopathy”
was thought to have a positive but transient influence:
“…what helped me was Zyban® and sports…”
Mrs. G.
“… before that I tried acupuncture, twice with
permanent needles, once just with regular needles…
did not help…”
Mrs. F.
“I was working with a magneopath and I was smoking
24 cigarettes a day back then, and then one week only
two cigarettes, that was a good experience…”
Mrs. D.
Many subjects emphasized that in previous attempts
to cease smoking an intensive physical exercise program
was very helpful.
“…I did do a lot of sports, but at the end of the day,
I did not find it difficult…”
Mrs. C.
Other measures included the use of licorice for oral
stimulation and reading Allen Carr’s Easy Way to Stop
Smoking [40] in order to enhance motivation.
“I had a phase four to five years ago and that went
relatively well…relatively soon smoking was not an
issue anymore, actually the opposite, I found it
disgusting. The missing stimulation was difficult,
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I started with licorice as a replacement, because I was
missing the sucking, so I began to suck on that licorice
[laughing], that helped, but I permanently had a piece
of wood in my mouth, but it also calmed me…”
Mrs. E.
“I had a time when I was not smoking for 15 months…
I read a book by Alan Carr, that really helped me and
I sill believe if I had the money that I would like to
take one of those courses.
Mrs. C.
Motivations, expectations, and reasons for participating
in a cessation program
All subjects addressed the issue of motivation, often
spontaneously as part of their initial narrative, regardless
of whether they had decided to participate in the cessa-
tion program. We identified three themes regarding
motivation, but there was significant overlap between
themes, and eight participants described more than one
motivational factor.
The most commonly expressed theme was health
concerns. Subjects were afraid of serious negative con-
sequences to their personal wellbeing from smoking.
Additionally, many subjects described perceived negative
effects on their physical resilience.
“…from my point of view the damage (of smoking) is
mostly physical in nature, it puts a limitation on your
life, on your fitness, and in the long term all these
damages to your health, yes…”
Mr. B.
“…now it is really, the exercise, the new kinesthesia
which you get when you say no, I don’t want to give up
now, because that just does not fit together, I cannot
work out 5 hours per week and then smoke 10
cigarettes per day, that does not work and this is
where I draw the line…”
Mr. B.
“It all starts with your health, that it is somehow
harmful, and that you also feel it, I mean I was not
smoking for one year and I know how it is not to be
smoking, how you feel with that…”
Mrs. G.
An equally important motivational factor for many
individuals was the feeling of being addicted, a limitation
they described as a lack of personal freedom.
“[disadvantages] are for me more of psychological
nature, rather than physical, because I go to the doctor
on a regular basis to get a check up, I also get lung
X-rays frequently and then I am always relieved that I
can continue to smoke. It is more the lack of freedom…
that I am dependent on these cigarettes…”
Mrs. D.
“…and the really bad thing is this addiction, I find this
worse than all the damages to health. Just because you
must have one, it is not your will that is deciding, now
I am gonna have a smoke and now not, it is not like
eating chocolate, you really must [smoke] …”
Mrs. C.
As expected, social factors were also frequently men-
tioned. Immediate family members, relatives and sig-
nificant others were important external motivational
influences. Many participants felt a moral obligation to
avoid harming their offspring. Subjects of both genders
described previous phases of abstinence during preg-
nancy and caring for children.
“… I mean when I first stopped smoking my
motivation was my family, my two kids, my two
babies at home, that was enough back then…”
Mr. B.
“…[I stopped smoking] during pregnancy and
lactation…it was clear to me that I would have
had remorse…”
Mrs. H.
“During the last pregnancy… I stopped smoking
for two to three weeks…I made sure that I did
not inhale…”
Mrs. F.
Interestingly, two subjects specifically viewed themselves
as socially excluded or even harassed by non-smokers and
felt that these feelings had contributed to their decision to
quit smoking.
“Today it is also partially difficult, where can you go,
without getting looked at…”
Mrs. F.
Less surprisingly, financial stress was another frequently
mentioned external social factor.
“I don’t see a benefit, you know every reasonable
human sees first, that it costs a lot of money, which
you could use otherwise…”
Mrs. J.
“…and also the cost, that is something…”
Mrs. F.
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Thoughts about an “optimal” smoking cessation
intervention
Our study participants offered their own suggestions for
the design of smoking cessation programs. Interestingly,
many subjects viewed an inpatient treatment setting
in a “specialized” hospital as desirable and were ready
to participate in such treatment even for several
weeks. They associated inpatient treatment with less
severe withdrawal symptoms because of continuous
access to health care professionals and protection
against relapse.
“maybe something more like an inpatient program, a
little bit like a vacation program, with occupational
therapy, and when I have a crisis, someone is right
there for me. I have been thinking about entering a
clinic…for a smoking cessation program, and then I
think this is a bit too much [for smoking], everybody
else can do without it, but maybe it would be
something for me… if there would be care 24/7.”
Mrs. D.
“and what I would immediately do is to go somewhere
for two or three weeks like a heroin addict. I think it is
kind of sad, that something like this does not exist for
smokers, because I have seen this with my brother who
is a heroin addict. I don't see a difference between us
[smokers] and heroin-addicted humans. In my
perception I am chasing after a cigarette just as he is
chasing after an injection, just another form, same
thing. It’s a kind of pity that there is no place where
I can have a controlled withdrawal…”
Mrs. G.
Other subjects suggested even more extreme methods,
ranging from a “sleep regimen” to being abandoned on a
distant island. Furthermore, several participants were
interested in hypnosis.
“… I believe something would have to be changed
inside my head [laughs]. I do have the feeling that,
I don’t know if it is possible, to participate in a week
long “sleeping regimen” in a hospital…
Mrs. J.
“Or something without side effects, that doesn’t bother
and doesn't stress me…and I have to add, that I have
something in my head that I would like to try, which
has fascinated me for a long time…hypnosis…”
Mrs. G.
There was some overlap in this theme with the desire
for a “quick fix” or miracle cure, something fast, with no
symptoms of withdrawal.
“…the best idea would be to find the switch in your
brain, where you can just turn it off…”
Mrs. F.
“…and of course you wish that someone just has a
solution for you…”
Mrs. E.
“I haven’t given up on it yet, I really want to quit, but,
it is still incomprehensible for me, how I am supposed
to do that, how I can outsmart myself. Last time it
just did not happen, I am still waiting, it sounds
stupid, for an inspiration, for something that I
suddenly can manage it with.”
Mrs. F.
Some participants suggested that a group setting might
be more beneficial than individual counseling.
“…I believe that if it is done in a group of other
persons who are affected, that say we all want to stop
now, and are motivating each other or can talk about
difficulties, than it might create good feelings, that one
is not alone with this.”
Mr. K.
Interestingly some subjects felt that financial penalties
or a vivid description of the harmful consequences of
tobacco use might lead to success.
“…Education, ah, ‘shock therapy,’ although some say it
is not helpful, but it supported me a lot, back when a
friend of mine was diagnosed with lung cancer and
my family practitioner told me that I have chronic
‘smokers cough’ and what that all means and what
kind of lung diseases there are, that really alarmed
me… you tend to block these things out of your
mind…”
Mrs. C.
“…Coaching could be more intensive and more
demanding. I think there should be more pressure
from the side of the therapist…and maybe even some
financial commitment, defining targets and stages,
and also rewards and penalties…”
Mr. B.
One participant, who was aware of his dual-diagnosis,
explained that he viewed psychiatric treatment for his
ADHD as the primary strategy to stop smoking.
“…In my case it would need psychiatric support, it
can be done together with the treatment of ADHD,
because it fits there. Because there are some studies
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that say nicotine helps people with ADHD, and
because of that it is another hazard, and it is also
an extra step for people with ADHD, because it is
not just an addiction, but almost medicine.”
Mr. L.
Perceptions about a smoking cessation program
specifically designed for adults with ADHD
While four subjects were reluctant to comment, one
participant opposed a program designed for adults with
ADHD. Another subject similarly noted that there were
many smokers without ADHD who had difficulty quitting.
“…I am not sure about it, because there are many
people out there, who more or less have it, and who
have lived with it without knowing…and that is why…”
Mrs. G.
“…I could not say, but I see in everybody how difficult
it is [to stop smoking].”
Mrs. H.
The other study subjects supported specific counseling
for individuals with ADHD, as they felt that people with
ADHD have unique smoking patterns. They felt that a
specifically designed program should expect a worsening
of ADHD symptoms during nicotine withdrawal, help
develop coping strategies for these symptoms, consider
inattentive symptoms and symptoms of “inner tension,”
deliver support during “failures,” engage participants
more actively, and involve family members.
“…the major difference I see is that people with ADHD
have a harder time quitting smoking than people
without ADHD…and with me I am just scared to
change, the inhibition threshold increases because
you are chaotic and [when you stop] I am afraid that
the chaos just increases, and that is why you wait
for a more quiet moment in life…and I think these
are the kind of things that people with no ADHD
would not think.”
Mrs. C.
“…the form of consultation [for smokers with ADHD]
should be fundamentally different. That you really
look if someone can keep the attention focused on the
course, that you also support more in case of failure,
and that you keep at it, and keep at it, because for
smokers with ADHD it is not necessarily a motivational
problem… And the topic of compensation is more
important, because of the strong inner tension that
most experience, that is something that contributes
to smoking…”
Mrs. E.
“I could imagine that it is more important to involve
family and friends in smokers with ADHD, compared
to other participants, because this way there would
be a bit more control, responsibility, support through
children, whatever…I think the social community
is more important in patients with ADHD than in
others…”
Mr. B.
One participant suggested that screening for ADHD in
smokers should be done more routinely, pointing out
that he was diagnosed only at a later age.
“…ADHD people are usually more nervous, and they
are always sped up, and so on, and the most people
with ADHD I know smoke, and smoke a lot, and you
have to specifically reach out to these people and also
the ones who do not know that they might suffer from
that illness, because many people with ADHD that I
know, they don’t know that they have it, so it starts
earlier on…I only learned about my diagnosis when
I was 50 years old…”
Mr. A.
Another subject was convinced that a cessation program
should not focus on the use of tobacco, but on substance
misuse in general.
“… I have a lot of experience with ADHD…someone
who does not have this sort of experience, who has
ADHD and has to fight with addiction, they might
need more alternatives… what are these alternatives,
and you have to look how it really is with ADHD, and
with this inner tension, because you will definitely
need something. It should not just be about smoking.
The program should be about addiction. I know
different people with ADHD and they all have their
problems and different strategies to approach them. So
we need to know about alternatives, and many
individuals with ADHD really have to fight addiction
and dependence. Many smoke cannabis like crazy to
calm down, others use cocaine…”
Mr. A.
Discussion
This study describes the views and experiences of adults
with ADHD regarding smoking cessation and withdrawal,
their expectations and motivations for participation in a
smoking cessation program, and their ideas about optimal
support during the withdrawal process.
The vast majority of study participants had a long his-
tory of tobacco use. Sixteen subjects were rated “highly”
or “very highly” dependent on nicotine according to the
FTND, and many reported several previous attempts to
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quit smoking. Subjects had frequently relapsed after short
periods of abstinence, and they described symptoms of
irritability, nervousness, restlessness, insomnia, depression,
anxiety, and weight gain during withdrawal. These self-
reported symptoms do not significantly differ from pre-
viously reported self- and observer-rated withdrawal symp-
toms of self-quitters in non-clinical samples [41, 42].
Some data indicate that adult smokers with ADHD
experience worse withdrawal symptoms, depressive mood
swings, somatic symptoms, and craving after stopping
nicotine use, compared to smokers without ADHD
[43–45]. For example, McClernon et al investigated forty
moderate- to heavy smoking adults with and without
ADHD during a 12-day quit study; they reported greater
withdrawal severity among smokers with ADHD, espe-
cially in the first 5 days, which was independent of
effects on ADHD symptoms [44]. Our participants’
experiences are in accord with these findings. Fewer
studies have evaluated the link between smoking cessa-
tion and potential worsening of ADHD symptoms. Some
authors argue that there is a significant overlap between
nicotine withdrawal symptoms and symptoms of ADHD
and therefore urge caution on this subject [46]. Others,
however, have reported that smoking withdrawal symp-
toms occur independently from changes in ADHD
symptoms [44]. Our participants almost unanimously
believed that smoking cessation resulted in a worsening
of their ADHD symptoms, even after initial nicotine
withdrawal symptoms had subdued.
Our study subjects described a wide variety of smoking
intervention and self-help strategies that they had used in
previous cessation attempts, including both evidence- and
non-evidence-based approaches. Several had tried acu-
puncture, “magnetophathy,” and homeopathy. Similarly, a
recent population-based study of 988 Swiss smokers
found a high preference for non-evidence-based treatment
strategies, including acupuncture and hypnosis, although
both treatments are in few instances prescribed by physi-
cians [47]. The authors of one previously mentioned study
argue that a “lack of knowledge of their ineffectiveness,
the fact that more educated subjects tend to complement
effective treatments with alternative methods and the
media coverage by the lay press” may contribute to the
popularity of alternative treatments [47].
We identified three interrelated motives to quit smo-
king, though there was some overlap between motives
and the majority of our participants gave multifactorial
explanations. The first motive, health concerns, was
named by the majority of the participants and was
expressed most frequently. Subjects were afraid of ser-
ious future deteriorations in their health status and of
negative health consequences in general. The second
motive, the feeling of being addicted, was associated
with a lack of personal freedom and independence.
The third motive, social factors, was mentioned as fre-
quently as the second motive, and it involved themes
such as family ties, perceived social undesirability, and
financial considerations. These findings are in accord
with the extensive literature on factors associated with
the desire to quit smoking in smokers without comor-
bid ADHD [48–52]. For example, Riedel et al investi-
gated a sample of 120 adolescent smokers, and they
reported that concerns about future health, current
health, and physical appearance; the cost of cigarettes;
and athletic performance were the most important
motivators to quit smoking [50]. A recent study on
“triggers” to quit smoking came to the conclusion that
individual factors, such as concerns for personal
health, are a culturally independent motivator to stop
smoking and are more important than interpersonal
factors such as societal disapproval [53].
As demonstrated by their views about an optimal
smoking cessation program, participants had some mis-
conceptions about nicotine dependence. For example,
subjects did not understand its status as a substance use
disorder; some thought an optimal treatment program
would allow them to immediately and permanently ab-
stain from smoking without experiencing any symptoms
of withdrawal. The motive of a desire for a “quick fix”
was common, similar to a desire for finding a “switch in
the brain” or a “miracle solution.” Subjects who voiced
this motive also suggested a wide variety of measures,
including intensive inpatient treatment, financial penal-
ties for non-compliance, non-evidence-based treatment
strategies (e.g., hypnosis or sleep therapy), or even the
fantasy of abandonment in a distant location.
Other findings in this context were more heteroge-
neous. Some participants thought group therapy should
be part of an optimal treatment program, and another
participant suggested that focusing primarily on treating
ADHD would best change smoking patterns. Fur-
thermore, none of our study subjects spontaneously
expressed interest in a long-term nicotine maintenance
approach, instead focusing on complete abstinence, even
though by the end of the smoking cessation program no
subjects were able to maintain abstinence, and half of
the participants had returned to their initial pattern of
tobacco use. This finding is consistent with previous
reports that smokers prefer cessation to nicotine main-
tenance, and that some smokers even perceive nicotine
replacement as harmful [54, 55].
Finally we explored perceptions about a smoking
cessation program specifically designed for adults with
ADHD. The majority of subjects felt a need for this type
of specific counseling, as they considered their ADHD
symptoms a significant complication during nicotine
withdrawal. Most commonly, subjects called for a treat-
ment protocol that would take into account worsened
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ADHD symptoms and prepare them with coping stra-
tegies specific for these symptoms.
This study has certain limitations: AF, a clinical psy-
chologist, who also provided counseling as part of the
smoking cessation program, conducted all interviews
with SCP participants. This may have influenced parti-
cipant responses on SCP. However, we also included
twelve subjects from different locations, who had not
participated in the SCP, broadening the sample of
participant views. Furthermore data on nicotine con-
sumption patterns are self-reported; relying on an active
reconstruction process called recall, and may have
resulted in a recall bias.
Conclusions
In summary, adults smokers with ADHD had made sev-
eral attempts to quit (often using non-evidence-based
treatments), experienced those efforts as highly stressful,
felt intense symptoms of withdrawal, and relapsed early
and frequently. Subjects also frequently noted a per-
ceived worsening of ADHD symptoms with phases of
prolonged nicotine abstinence. Their motives to quit
smoking were very similar to smokers without ADHD,
including health concerns, the feeling of being addicted,
and social factors. The majority of subjects who partici-
pated in the smoking cessation program viewed it as
helpful, and they highlighted the benefits of both struc-
ture and counseling. Additionally, many participants in
this study favored a smoking cessation program specifi-
cally for individuals with ADHD. Many believed that
nicotine withdrawal was complicated by symptoms of
ADHD and that an ADHD-specific smoking cessation
program should address specific symptoms of this dis-
order. Ultimately, considering that both the initiation of
psychiatric services and adherence to those services are
closely associated with personal attitudes and beliefs,
we offer these findings in the hope that future cessation
interventions for smokers with ADHD might better
serve this vulnerable subgroup [56, 57].
Abbreviations
ADHD, Attention-Deficit/Hyperactivity Disorder; ADHS-SB, Attention-Deficit/
Hyperactivity Self-Report Scale; FTND, Fagerstrom Test for Nicotine
Dependence; ICD-10, 10th revision of the International Statistical Classification
of Diseases and Related Health Problems; SUD, substance use disorder;
WRAADDS, Wender-Reimherr Adult Attention Deficits Disorders Scale; WRI,
Wender-Reimherr Interview; WURS-k, Wender Utah Rating Scale
Acknowledgements
We wish to acknowledge the work of Corinna Fales (New York), who
copyedited this manuscript.
Funding
Michael Liebrenz was financially supported by the Prof. Dr. Max Cloëtta
Foundation, Zurich, Switzerland, and the Uniscientia Foundation, Vaduz,
Principality of Liechtenstein. Both foundations had no role in the study
design, in the analysis and interpretation of data, in the writing of the
report, or in the decision to submit the paper for publication.
Availability of data and materials
By including the original transcripts (data) of all individuals it might be
possible to identify participants for those closely related to them. Transcripts
include too many specifics pieces of information. For example, there are
names of specific towns/cities, occupations, occupations of family members,
places of employment etc. Since we assured confidentially to participant,
this data cannot be stored publically. Public availability would compromise
patient privacy.
In accordance with BMC Psychiatry’s sharing policy, excerpts of the
transcripts relevant to this study are available on request by contacting
Michael Liebrenz: Michael.Liebrenz@fpd.unibe.ch or Anna Buadze
Anna.Buadze@puk.zh.ch. Please note that identifying/confidential patient
data will not be shared.
Authors’ contributions
DE, AF, RN and ML contributed to the design and the coordination of the
study. RN, AF, A-CB, NH, AH, AB and ML contributed to data interpretation.
ML prepared a first draft of the manuscript. CEF revised the manuscript
critically for important intellectual content. All authors read and approved
the final version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
All participants provided their consent for publication.
Ethics approval and consent to participate
Ethics approval for the study (E-23_2009) was received from Zurich’s
Cantonal Ethics Committee “Kantonale Ethikkommission Zürich” (official
notice of decision 3rd of March 2010). All participants provided their written
informed consent to the study, specifically to the recorded interviews.
Author details
1Department of Forensic Psychiatry, Institute of Forensic Medicine, University
of Bern, Falkenplatz 16-18, Bern 3012, Switzerland. 2Department of Psychiatry,
New York State Psychiatric Institute, Columbia University Medical Center,
1051 Riverside Drive, New York, NY 10032, USA. 3Department of Psychiatry,
Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich,
Zurich, Switzerland. 4Institute for General Practice and Health Services
Research, University of Zurich, Pestalozzistrasse 24, 8091 Zurich, Switzerland.
Received: 16 June 2015 Accepted: 7 June 2016
References
1. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS. Cigarette smoking
in adult patients diagnosed with attention deficit hyperactivity disorder.
J Subst Abuse. 1995;7(3):373–8.
2. Tercyak KP, Lerman C, Audrain J. Association of attention-deficit/hyperactivity
disorder symptoms with levels of cigarette smoking in a community sample
of adolescents. J Am Acad Child Adolesc Psychiatry. 2002;41(7):799–805.
3. Frei A, Hornung R, Eich D. Tobacco consumption of adults diagnosed with
ADHD. Nervenarzt. 2010;81(7):860–6.
4. Faraone SV, Antshel KM. Diagnosing and treating attention-deficit/
hyperactivity disorder in adults. World Psychiatry. 2008;7(3):131–6.
5. Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH, Rose JE,
March J. Nicotine effects on adults with attention-deficit/hyperactivity
disorder. Psychopharmacology (Berl). 1996;123(1):55–63.
6. Shytle RD, Silver AA, Wilkinson BJ, Sanberg PR. A pilot controlled trial of
transdermal nicotine in the treatment of attention deficit hyperactivity
disorder. World J Biol Psychiatry. 2002;3(3):150–5.
7. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. ADHD is associated
with early initiation of cigarette smoking in children and adolescents. J Am
Acad Child Adolesc Psychiatry. 1997;36(1):37–44.
8. Glass K, Flory K. Why does ADHD confer risk for cigarette smoking? A review
of psychosocial mechanisms. Clin Child Fam Psychol Rev. 2010;13(3):291–313.
9. Potter AS, Newhouse PA. Acute nicotine improves cognitive deficits in
young adults with attention-deficit/hyperactivity disorder. Pharmacol
Biochem Behav. 2008;88(4):407–17.
Liebrenz et al. BMC Psychiatry  (2016) 16:208 Page 10 of 11
10. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the
executive function theory of attention-deficit/hyperactivity disorder:
a meta-analytic review. Biol Psychiatry. 2005;57(11):1336–46.
11. Gehricke JG, Loughlin SE, Whalen CK, Potkin SG, Fallon JH, Jamner LD,
Belluzzi JD, Leslie FM. Smoking to self-medicate attentional and emotional
dysfunctions. Nicotine Tob Res. 2007;9 Suppl 4:S523–536.
12. Sousa NO, Grevet EH, Salgado CA, Silva KL, Victor MM, Karam RG, Vitola ES,
Picon FA, Zeni GD, Rohde LA, et al. Smoking and ADHD: an evaluation of
self medication and behavioral disinhibition models based on comorbidity
and personality patterns. J Psychiatr Res. 2011;45(6):829–34.
13. Kollins SH, McClernon FJ, Fuemmeler BF. Association between
smoking and attention-deficit/hyperactivity disorder symptoms in a
population-based sample of young adults. Arch Gen Psychiatry.
2005;62(10):1142–7.
14. Berlin I, Hu MC, Covey LS, Winhusen T. Attention-deficit/hyperactivity disorder
(ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in
adult smokers with ADHD. Drug Alcohol Depend. 2012;124(3):268–73.
15. Covey LS, Manubay J, Jiang H, Nortick M, Palumbo D. Smoking cessation
and inattention or hyperactivity/impulsivity: a post hoc analysis. Nicotine
Tob Res. 2008;10(12):1717–25.
16. Tamm L, Adinoff B, Nakonezny PA, Winhusen T, Riggs P: Attention-Deficit/
Hyperactivity Disorder Subtypes in Adolescents with Comorbid Substance-
Use Disorder. Am J Drug Alcohol Abuse. 2011;38(1):93–100.
17. Liebrenz M, Frei A, Fisher CE, Gamma A, Buadze A, Eich D. Adult attention-
deficit/hyperactivity disorder and nicotine use: a qualitative study of patient
perceptions. BMC Psychiatry. 2014;14:141.
18. Nichter M, Carkoglu A. Reconsidering stress and smoking: a qualitative
study among college students. Tob Control. 2007;16(3):211–4.
19. Nichter M. Smoking: what does culture have to do with it? Addiction.
2003;98 Suppl 1:139–45.
20. Yong HH, Borland R, Cooper J, Cummings KM. Postquitting experiences
and expectations of adult smokers and their association with subsequent
relapse: findings from the International Tobacco Control (ITC) Four Country
Survey. Nicotine Tob Res. 2010;12(Suppl):S12–19.
21. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term
abstinence among untreated smokers. Addiction. 2004;99(1):29–38.
22. Hughes JR. Effects of abstinence from tobacco: etiology, animal models,
epidemiology, and significance: a subjective review. Nicotine Tob Res.
2007;9(3):329–39.
23. Borland R, Yong HH, Balmford J, Cooper J, Cummings KM, O’Connor RJ,
McNeill A, Zanna MP, Fong GT. Motivational factors predict quit attempts
but not maintenance of smoking cessation: findings from the International
Tobacco Control Four country project. Nicotine Tob Res. 2010;12(Suppl):S4–11.
24. Zhou X, Nonnemaker J, Sherrill B, Gilsenan AW, Coste F, West R. Attempts
to quit smoking and relapse: factors associated with success or failure from
the ATTEMPT cohort study. Addict Behav. 2009;34(4):365–73.
25. Klassen LJ, Bilkey TS, Katzman M, Chokka P. Comorbid Attention Deficit/
Hyperactivity Disorder and Substance Use Disorder: Treatment
Considerations. Curr Drug Abuse Rev 2012;5(3):190–198.
26. Echebarria Echabe A, Sanjuan Guillen C, Agustin Ozamiz J. Representations
of health, illness and medicines: coping strategies and health-promoting
behaviour. Br J Clin Psychol. 1992;31(Pt 3):339–49.
27. Frei A. Aufmerksamkeitsdefizit -/Hyperaktivitätsstörung (ADHS) und
Tabakkonsum bei Erwachsenen Zusammenänge und Rauchentwöhnung in
einer Schweizer Stichprobe. In: Zurich Universitätsspital Zürich,
Psychiatrische Universitätsklinik Zürich. 2007.
28. Eich D, Angst J, Frei A, Ajdacic-Gross V, Rossler W, Gamma A. A new rating
scale for adult ADHD based on the Symptom Checklist 90 (SCL-90-R). Eur
Arch Psychiatry Clin Neurosci. 2012;262(6):519–28.
29. Cornuz J. Smoking cessation–a central role for physicians. Ther Umsch.
2005;62(9):655–60.
30. US Public Health Service, & Office of the Surgeon General. Tobacco
cessation guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S530.
31. Barkley RA, Murphy KR, Fischer M. ADHD in adults : what the science says.
New York: Guilford Press; 2008.
32. Retz-Junginger P, Retz W, Blocher D, Stieglitz RD, Georg T, Supprian T,
Wender PH, Rosler M. Reliability and validity of the Wender-Utah-Rating-
Scale short form. Retrospective assessment of symptoms for attention
deficit/hyperactivity disorder. Nervenarzt. 2003;74(11):987–93.
33. Rosler M, Retz W, Retz-Junginger P, Thome J, Supprian T, Nissen T, Stieglitz
RD, Blocher D, Hengesch G, Trott GE. Tools for the diagnosis of attention-
deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire
and diagnostic checklist. Nervenarzt. 2004;75(9):888–95.
34. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom
Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance
Questionnaire. Br J Addict. 1991;86(9):1119–27.
35. Hurt RD, Croghan GA, Beede SD, Wolter TD, Croghan IT, Patten CA.
Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal
symptom relief, and carbon monoxide and plasma cotinine levels. Arch
Pediatr Adolesc Med. 2000;154(1):31–7.
36. Faller H, Frommer J. Qualitative Psychotherapieforschung. Grundlagen und
Methoden. Heidelberg: Asanger; 1994.
37. Mayring P. Qualitative content analysis. In: Forum qualitative
sozialforschung/forum: qualitative social research: 2000. 2000.
38. Kuckartz U. MAXQDA: Qualitative data analysis. Berlin: VERBI software; 2007.
39. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative
research (COREQ): a 32-item checklist for interviews and focus groups.
Int J Qual Health Care. 2007;19(6):349–57.
40. Carr A. The easy way to stop smoking [Rev. and updated]. New York:
Sterling Pub. Co.; 2004.
41. Hughes JR. Tobacco withdrawal in self-quitters. J Consult Clin Psychol.
1992;60(5):689–97.
42. Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW. Symptoms of
tobacco withdrawal. A replication and extension. Arch Gen Psychiatry.
1991;48(1):52–9.
43. Pomerleau CS, Downey KK, Snedecor SM, Mehringer AM, Marks JL,
Pomerleau OF. Smoking patterns and abstinence effects in smokers with
no ADHD, childhood ADHD, and adult ADHD symptomatology. Addict
Behav. 2003;28(6):1149–57.
44. McClernon FJ, Van Voorhees EE, English J, Hallyburton M, Holdaway A,
Kollins SH. Smoking withdrawal symptoms are more severe among
smokers with ADHD and independent of ADHD symptom change: results
from a 12-day contingency-managed abstinence trial. Nicotine Tob Res.
2011;13(9):784–92.
45. McClernon FJ, Kollins SH, Lutz AM, Fitzgerald DP, Murray DW, Redman C,
Rose JE. Effects of smoking abstinence on adult smokers with and without
attention deficit hyperactivity disorder: results of a preliminary study.
Psychopharmacology (Berl). 2008;197(1):95–105.
46. Gray KM, Baker NL, Carpenter MJ, Lewis AL, Upadhyaya HP. Attention-deficit/
hyperactivity disorder confounds nicotine withdrawal self-report in adolescent
smokers. Am J Addict. 2010;19(4):325–31.
47. Marques-Vidal P, Melich-Cerveira J, Paccaud F, Waeber G, Vollenweider P, Cornuz
J. High expectation in non-evidence-based smoking cessation interventions
among smokers–the CoLaus study. Prev Med. 2011;52(3-4):258–61.
48. Halpern MT, Warner KE. Motivations for smoking cessation: a comparison
of successful quitters and failures. J Subst Abuse. 1993;5(3):247–56.
49. Pederson LL, Bull SB, Ashley MJ, MacDonald JK. Quitting smoking: why,
how, and what might help. Tob Control. 1996;5(3):209–14.
50. Riedel BW, Robinson LA, Klesges RC, McLain-Allen B. What motivates
adolescent smokers to make a quit attempt? Drug Alcohol Depend.
2002;68(2):167–74.
51. Breitling LP, Rothenbacher D, Stegmaier C, Raum E, Brenner H. Older
smokers’ motivation and attempts to quit smoking: epidemiological
insight into the question of lifestyle versus addiction. Dtsch Arztebl Int.
2009;106(27):451–5.
52. Betzner AE, Boyle RG, Luxenberg MG, Schillo BA, Keller PA, Rainey J, Capesius
T, Saul JE. Experience of smokers and recent quitters with smokefree
regulations and quitting. Am J Prev Med. 2012;43(5 Suppl 3):S163–170.
53. Im PK, McNeill A, Thompson ME, Fong GT, Xu S, Quah AC, Jiang Y, Shahab
L. Individual and interpersonal triggers to quit smoking in China: a cross-
sectional analysis. Tob Control. 2015;24(Suppl 4):iv40-iv47.
54. Richter KP, McCool RM, Okuyemi KS, Mayo MS, Ahluwalia JS. Patients’ views
on smoking cessation and tobacco harm reduction during drug treatment.
Nicotine Tob Res. 2002;4 Suppl 2:S175–182.
55. Black A, Beard E, Brown J, Fidler J, West R. Beliefs about the harms of
long-term use of nicotine replacement therapy: perceptions of smokers
in England. Addiction. 2012;107(11):2037–42.
56. Britten N. Psychiatry, stigma, and resistance. Psychiatrists need to concentrate
on understanding, not simply compliance. BMJ. 1998;317(7164):963–4.
57. Noble LM, Douglas BC, Newman SP. What do patients expect of psychiatric
services? A systematic and critical review of empirical studies. Soc Sci Med.
2001;52(7):985–98.
Liebrenz et al. BMC Psychiatry  (2016) 16:208 Page 11 of 11
